Germany's Gerresheimer initiates sale of Centor, reschedules 2025 results amid probe
10/02/2026 22:06
Feb 10 (Reuters) - Gerresheimer GXIG.DE has initiated a sale of Centor, its U.S.-based packaging systems business, and rescheduled its 2025 results publication amid a probe into its revenue recognition and accounting practices, the medical equipment maker said on Tuesday. (Reporting by Chandni Shah in Bengaluru; Editing by Vijay Kishore) ((Chandni.shah@thomsonreuters.com;))
Recent news on Gerresheimer AG
See all newsGermany's Gerresheimer prelim Q3 revenue rises on strong demand for drug delivery devices
Brief: Gerresheimer Reports Q3 Revenue Of EUR 605 Mln
Brief: Gerresheimer Completes Sale Of Centor
Brief: Gerresheimer Targets Leverage At Or Below 3x Net Debt To Ebitda
Gerresheimer gains as Q2 shows quarter-on-quarter recovery